Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Oragenics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Oragenics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Spencer John | Chief Financial Officer | – | Jul 7, 2026 | 1 |
| Telling Fred | Director | 948 | Jan 22, 2026 | 1 |
| Pope Charles L | Director | 25,471 | Dec 15, 2025 | 1 |
| Gandolfo John P | Director | – | Dec 15, 2025 | 1 |
| Koski Robert C | Director | 23,367Indirect | Dec 15, 2025 | 1 |
| Dunton Alan W | Director | 25,623 | Dec 15, 2025 | 1 |
| Giordano Natasha | Director | – | Dec 15, 2025 | 1 |
| Huffman Janet | CEO and CFO | 15,000 | Dec 15, 2025 | 1 |
| Odyssey Health, Inc. | 10% Owner | 0 | Jun 18, 2025 | 0 |
| Redmond J Michael | President | – | Sep 20, 2024 | 0 |
| Cassidy Bruce A. Sr. | Director | – | Sep 20, 2024 | 0 |
| Murphy Kimberly M | Director | 25,000 | Sep 20, 2024 | 0 |
| Sullivan Michael O'Keefe | Chief Financial Officer | 34,255 | Aug 2, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 (view filing) | Dec 12, 2025 | 41 days | Telling FredDirector | SSale | −210 | $0.94 | −$197.4 | −18.1%948 after | Amended |
| Jun 18, 2025 (view filing) | Jun 17-18 | 1 day | Odyssey Health, Inc.10% Owner | SSaleCommon Stock - OGEN | −7.04K | $4.32 | −$30.4K | −100.0%0 after | 2 lots |
| Jun 16, 2025 (view filing) | Jun 13-16 | 3 days | Odyssey Health, Inc.10% Owner | SSaleCommon Stock - OGEN | −10.0K | $4.36 | −$43.6K | −58.7%7.04K after | 2 lots |
| Dec 9, 2024 (view filing)6:07 PM ET | Dec 6 | 3 days | Dunton Alan WDirector | SSale | −66 | $0.36 | −$23.76 | −0.3%25.6K after | |
| Dec 9, 2024 (view filing)4:23 PM ET | Dec 6 | 3 days | Telling FredDirector | SSale | −3.60K | $0.36 | −$1.29K | −9.4%34.7K after | |
| Dec 1, 2023 (view filing) | Nov 30 | 1 day | Telling FredDirector | SSale | −3.50K | $3.57 | −$12.5K | −8.4%38.3K after | |
| Jan 3, 2023 (view filing)4:20 PM ET | Dec 29, 2022 | 5 days | Koski Robert CDirector | SSale | −36.6K | $0.106 | −$3.88K | −17.2%176.2K after | |
| Jan 3, 2023 (view filing)4:20 PM ET | Dec 30, 2022 | 4 days | Koski Robert CDirector | SSale | −42.4K | $0.1055 | −$4.47K | −3.7%1.10M after | |
| Dec 16, 2022 (view filing)4:05 PM ET | Dec 14-15 | 2 days | Koski Robert CDirector | SSale | −165.5K | $0.1757 | −$29.1K | −12.6%1.14M after | 2 lots |
| Dec 15, 2022 (view filing)4:15 PM ET | Dec 14 | 1 day | Koski Robert CDirector | SSale | −4.50K | $0.175 | −$788.03 | −0.3%1.31M after | |
| Dec 12, 2022 (view filing)4:22 PM ET | Dec 9 | 3 days | Koski Robert CDirector | SSale | −48.8K | $0.197 | −$9.61K | −3.6%1.31M after | |
| Dec 9, 2022 (view filing)4:14 PM ET | Dec 8 | 1 day | Koski Robert CDirector | SSale | −13.0K | $0.20 | −$2.61K | −0.9%1.36M after | |
| Dec 1, 2022 (view filing)4:08 PM ET | Nov 29-30 | 2 days | Koski Robert CDirector | SSale | −400.0K | $0.1917 | −$76.7K | −22.5%1.38M after | 2 lots |
| Jun 21, 2022 (view filing)9:30 AM ET | Jun 17 | 4 days | Telling FredDirector | PPurchase | +10.1K | $0.286 | +$2.88K | +1.0%1.01M after | |
| May 25, 2022 (view filing)4:05 PM ET | May 23-24 | 2 days | Telling FredDirector | PPurchase | +82.2K | $0.2894 | +$23.8K | +9.0%999.9K after | 2 lots |
| May 23, 2022 (view filing)4:15 PM ET | May 20 | 3 days | Telling FredDirector | PPurchase | +65.7K | $0.2836 | +$18.6K | +7.7%917.7K after | |
| May 20, 2022 (view filing)4:15 PM ET | May 18-19 | 2 days | Telling FredDirector | PPurchase | +72.1K | $0.2765 | +$19.9K | +9.2%852.0K after | 2 lots |
| Apr 1, 2022 (view filing)4:05 PM ET | Mar 30-31 | 2 days | Telling FredDirector | PPurchase | +183.8K | $0.3593 | +$66.1K | +30.8%779.9K after | 2 lots |
| Mar 30, 2022 (view filing)2:41 PM ET | Mar 29 | 1 day | Sullivan Michael O'KeefeInterim PEO, CFO | PPurchase | +20.0K | $0.3461 | +$6.92K | +140.3%34.3K after | |
| Jan 3, 2022 (view filing)4:29 PM ET | Dec 30-31, 2021 | 4 days | Koski Robert CDirector | PPurchase | +1.00M | $0.4691 | +$469.1K | +128.8%1.78M after | 2 lots |